Jun 28th, 2016
Mylan CEO Bresch on Brexit Exposure, Regulation
Heather Bresch, chief executive officer at Mylan, discusses the company's business in the U.K., exposure to Brexit, the importance of generics to the pharmaceutical industry, the effects of U.S. regulation, and drug pricing. She speaks with Bloomberg's David Westin on "Bloomberg ‹GO›." (Source: Bloomberg)
